Viewing StudyNCT00410774



Ignite Creation Date: 2024-05-05 @ 5:15 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00410774
Status: TERMINATED
Last Update Posted: 2012-09-17
First Post: 2006-12-11

Brief Title: Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery
Sponsor: University of California San Francisco
Organization: University of California San Francisco

Organization Data

Organization: University of California San Francisco
Class: OTHER
Study ID: CDR0000517330
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of California San Francisco
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH